Méryl Thomas
Impact in
-
- MicroRNA in disease regulation
-
- Histone Deacetylase Inhibitors Research
- Protein Degradation and Inhibitors
- RNA Interference and Gene Delivery
- Advanced biosensing and bioanalysis techniques
- Circular RNAs in diseases
Papers in
-
- RNA Interference and Gene Delivery 3
- Advanced biosensing and bioanalysis techniques 3
- Protein Degradation and Inhibitors 2
- Histone Deacetylase Inhibitors Research 2
- Circular RNAs in diseases 2
- RNA modifications and cancer 2
-
- MicroRNA in disease regulation 5
- Co-authors
- Alexander Deiters (7 shared papers)Colleen M. Connelly (4 shared papers)Yuta Naro (3 shared papers)Edward B. Holson (3 shared papers)Florence F. Wagner (3 shared papers)Jennifer Gale (2 shared papers)Michel Weïwer (2 shared papers)Nicholas Ankenbruck (3 shared papers)
- Journals
- Journal of Medicinal Chemistry (3 papers)Bioorganic & Medicinal Chemistry (2 papers)ACS Chemical Biology (1 paper)Bioorganic & Medicinal Chemistry Letters (1 paper)SLAS DISCOVERY (1 paper)
- Partner nations
- United States
In The Last Decade
Méryl Thomas
10 papers receiving 409 citations
Peers
Comparison fields: 5 of 74
- Cancer Research 116
- Molecular Biology 327
- Hepatology 27
- Oncology 76
- Organic Chemistry 63
Countries citing papers authored by Méryl Thomas
This map shows the geographic impact of Méryl Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Méryl Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Méryl Thomas more than expected).
Fields of papers citing papers by Méryl Thomas
This network shows the impact of papers produced by Méryl Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Méryl Thomas. The network helps show where Méryl Thomas may publish in the future.
Co-authors
The 25 scholars most cited alongside Méryl Thomas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 102 | |
| 2 | 2016 | 66 | |
| 3 | 2012 | 55 | |
| 4 | 2018 | 50 | |
| 5 | 2015 | 47 | |
| 6 | 2014 | 28 | |
| 7 | 2013 | 27 | |
| 8 | 2016 | 19 | |
| 9 | 2019 | 15 | |
| 10 | 2022 | 6 |
About Méryl Thomas
Méryl Thomas is a scholar working on Molecular Biology, Cancer Research, Cellular and Molecular Neuroscience, Oncology and Epidemiology, having authored 10 papers that have together received 415 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (5 papers), RNA Interference and Gene Delivery (3 papers), Advanced biosensing and bioanalysis techniques (3 papers), Protein Degradation and Inhibitors (2 papers), Histone Deacetylase Inhibitors Research (2 papers), Circular RNAs in diseases (2 papers), RNA modifications and cancer (2 papers) and Hepatitis B Virus Studies (1 paper). The work is most often cited by research in Cancer Research (116 citations), Molecular Biology (327 citations), Hepatology (27 citations), Oncology (76 citations) and Organic Chemistry (63 citations). Méryl Thomas has collaborated with scholars based in United States. Frequent co-authors include Alexander Deiters, Colleen M. Connelly, Yuta Naro, Edward B. Holson, Florence F. Wagner, Jennifer Gale, Michel Weïwer, Nicholas Ankenbruck, David E. Olson and Laura Gardner. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry, ACS Chemical Biology, Bioorganic & Medicinal Chemistry Letters and SLAS DISCOVERY.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.